Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (1 trial)
doxorubicin (Doxil) (1 trial)
naltrexone (revia) (1 trial)
rituximab (rituxan) (1 trial)
vincristine (oncovin) (1 trial)
Leukemia (Phase 3)
Leukemia, B-Cell (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Trials (1 total)
Trial APIs (6 total)